Novavax
NVAX
#5687
Rank
โ‚น124.38 B
Marketcap
โ‚น753.83
Share price
-5.45%
Change (1 day)
25.01%
Change (1 year)

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of June 2026 : -โ‚น17.84 Billion

According to Novavax's latest financial reports the company has -โ‚น17.84 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-โ‚น11.47 Billion-78.57%
2024-12-31$-โ‚น53.52 Billion-10.33%
2023-12-31$-โ‚น59.69 Billion13.75%
2022-12-31$-โ‚น52.47 Billion100.46%
2021-12-31$-โ‚น26.18 Billion-157.06%
2020-12-31$โ‚น45.87 B-445.8%
2019-12-31$-โ‚น13.27 Billion12.97%
2018-12-31$-โ‚น11.75 Billion80.77%
2017-12-31$-โ‚น6.5 Billion1623.55%
2016-12-31$-โ‚น0.38 Billion-101.94%
2015-12-31$โ‚น19.44 B33.65%
2014-12-31$โ‚น14.55 B15.9%
2013-12-31$โ‚น12.55 B185.79%
2012-12-31$โ‚น4.39 B54.23%
2011-12-31$โ‚น2.84 B7.66%
2010-12-31$โ‚น2.64 B-18.48%
2009-12-31$โ‚น3.24 B48.45%
2008-12-31$โ‚น2.18 B-11.66%
2007-12-31$โ‚น2.47 B-40.55%
2006-12-31$โ‚น4.16 B86.33%
2005-12-31$โ‚น2.23 B55.02%
2004-12-31$โ‚น1.44 B-11.93%
2003-12-31$โ‚น1.63 B322.73%
2002-12-31$โ‚น0.38 B-70.82%
2001-12-31$โ‚น1.32 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
โ‚น3.513 T-19,797.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น7.995 T-44,928.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น4.710 T-26,512.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น2.277 T-12,871.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น142.89 B-901.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น66.83 B-474.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-โ‚น19.26 Billion 7.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.81 B-104.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น42.49 Billion 138.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น31.93 B-279.02%๐Ÿ‡บ๐Ÿ‡ธ USA